Tempus ECG-AF vs cvi42 Auto Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Tempus ECG-AF

by Tempus AI, Inc.

cvi42 Auto Imaging

by Circle Cardiovascular Imaging Inc.

AI Verdict

Tempus ECG-AF is an AI-based algorithm focused on identifying patients at increased risk of developing atrial fibrillation within 12 months, utilizing 12-lead ECG recordings. Conversely, cvi42 Auto Imaging is an AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows. While both tools operate within cardiology, they address distinct diagnostic needs and process different types of medical data.

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your primary goal is to proactively identify older patients (65+) at elevated risk of developing new-onset atrial fibrillation within the next year, utilizing standard 12-lead ECGs. This tool is ideal for integrating into routine screenings to enable earlier intervention and follow-up before symptoms manifest.

View Tempus ECG-AF →

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if you require comprehensive, AI-powered analysis of cardiovascular MR and CT images for precise diagnosis, detailed quantitative assessment, and streamlined reporting. This solution is best suited for cardiologists and radiologists needing in-depth insights into cardiac function, tissue characteristics, and plaque burden for complex case management and treatment planning.

View cvi42 Auto Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Tempus ECG-AF	cvi42 Auto Imaging
Pricing	Contact vendor	Starts at $5000 per license
Deployment	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.	On-premise (standalone workstation or client/server)
BAA Available	Yes AI-estimated	Unknown
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cvi42 Auto Imaging

cvi42 Auto Imaging emphasizes 'AI-enabled automated contouring and segmentation' and 'simplified and smart reporting with infographics,' which directly streamline complex cardiovascular imaging analysis. While Tempus ECG-AF integrates into existing workflows, cvi42's features specifically address reducing manual effort and improving the user experience for intricate diagnostic tasks.

Clinical Value

Tempus ECG-AF

Tempus ECG-AF is an FDA-cleared algorithm for early identification of AF risk, offering a clear and specific clinical pathway with established CMS reimbursement. This provides a tangible and measurable impact on patient management and financial viability for healthcare providers.

Pricing & Value

Tempus ECG-AF

Tempus ECG-AF provides clear details on CMS reimbursement (CPT 0764T and CPT 0765T with a Medicare rate of $128.90), offering transparency and a direct path to financial return on investment for healthcare facilities. In contrast, cvi42 Auto Imaging's pricing is not publicly listed due to its complexity and modularity, making value assessment more challenging.

Enterprise Readiness

Tempus ECG-AF

Tempus ECG-AF explicitly states FDA clearance, HIPAA compliance, and the availability of a Business Associate Agreement (BAA), along with integration into healthcare facility systems. These are critical assurances for large-scale enterprise adoption and data governance.

Innovation

cvi42 Auto Imaging

cvi42 Auto Imaging demonstrates a broader scope of innovation by applying AI to automate and quantify complex analyses across multiple advanced imaging modalities (MR, CT) and offering vendor-neutral compatibility. This multi-modality approach for intricate imaging tasks represents a wider technological advancement in cardiovascular diagnostics.

Support & Docs

Tie

The provided structured facts do not contain specific information regarding the support and documentation offerings for either Tempus ECG-AF or cvi42 Auto Imaging. While both companies likely offer enterprise-level support, there is insufficient comparative detail to determine a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Tempus ECG-AF	cvi42 Auto Imaging
Name	Tempus ECG-AF	cvi42 Auto Imaging
Primary Function	AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up.	AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.
Input Modality	12-lead ECG recordings	Cardiovascular MR and CT images
Target Patient Population	Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.	Not specified
Specialties Supported	Cardiology, Geriatrics, Internal Medicine	Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring Tempus ECG-AF and cvi42 Auto Imaging.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. cvi42 Auto Imaging is an AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.

What type of patient data does each tool analyze?

Tempus ECG-AF analyzes 12-lead ECG recordings. cvi42 Auto Imaging analyzes cardiovascular MR and CT images.

Is there specific reimbursement information available for these tools?

Yes, for Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T, mapping to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025. For cvi42 Auto Imaging, pricing information is not publicly listed due to the complexity of licensing and modularity, requiring direct contact with the vendor. However, for its cvi42|Plaque module, Category I CPT code 75577 became effective January 1, 2026, for AI-enabled coronary plaque analysis, with Medicare and major insurers providing coverage.

What are the key differences in the patient populations or conditions each tool targets?

Tempus ECG-AF is intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months. cvi42 Auto Imaging supports a broader range of cardiovascular conditions by analyzing MR and CT images for functions like cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment), and vascular CT analysis.